Longevity & AgingResearch PaperPaywall

Resveratrol-Cucurbituril Complex Boosts Tooth Remineralization Without Toxicity

A novel molecular complex delivers resveratrol steadily into dentin for nearly a month, enhancing remineralization and bond strength safely.

Sunday, July 19, 2026 4 views
Published in J Dent Res
Molecular cage structure encapsulating a polyphenol molecule, surrounded by crystalline dentin mineral rods under microscopic blue light.

Summary

Researchers developed complexes of resveratrol encapsulated within cucurbit[n]uril (Q[6] and Q[7]) molecular cages to overcome the concentration-dependent toxicity of resveratrol while maximizing its dental benefits. The complexes released resveratrol steadily over nearly a month, inhibiting matrix metalloproteinases (MMPs) that degrade collagen in dentin. Compared to resveratrol alone, the Res@Q[n] complexes enhanced remineralization of demineralized dentin and type I collagen, improved microtensile bond strength, and reduced nanoleakage before and after aging — all without increasing cytotoxicity. This approach offers a promising strategy to extend the durability of dental bonding procedures.

Detailed Summary

Dental bonding durability is a long-standing clinical challenge. When dentin is prepared for bonding, collagen fibers in deeper layers become exposed and vulnerable to enzymatic degradation by matrix metalloproteinases (MMPs). Simultaneously, demineralized zones can form that weaken the bond interface over time. Addressing both problems simultaneously — promoting remineralization and inhibiting MMPs — has been difficult without causing cellular toxicity.

Resveratrol, a well-studied natural polyphenol found in grapes and red wine, has shown promise in inhibiting MMPs and supporting dentin remineralization. However, its benefits are concentration dependent, and higher effective doses introduce cytotoxicity, limiting clinical utility. To resolve this, the research team encapsulated resveratrol within cucurbit[n]uril molecular cages (specifically Q[6] and Q[7]), forming Res@Q[n] complexes designed for controlled, sustained release.

The complexes were characterized using analytical chemistry and quantum chemical analysis. In laboratory experiments, Res@Q[n] released resveratrol steadily over nearly a month. Compared to free resveratrol, the complexes demonstrated stronger MMP-9 inhibition, more pronounced remineralization of both recombinant type I collagen and actual dentin samples, and significantly improved microtensile bond strength. Nanoleakage — a marker of bond interface degradation — was also substantially reduced, even after aging stress tests.

Critically, the complexes achieved these outcomes without the cytotoxicity associated with high-dose free resveratrol, suggesting the encapsulation approach modulates bioavailability in a clinically favorable way.

Implications extend beyond dentistry. Controlled delivery of polyphenols like resveratrol via supramolecular chemistry could inform strategies in tissue regeneration and anti-aging applications where sustained low-level polyphenol exposure is desirable. Caveats include the study's in vitro nature and limited translation data for clinical dental bonding protocols.

Key Findings

  • Res@Q[n] complexes released resveratrol steadily for nearly one month, enabling sustained MMP inhibition.
  • Complexes significantly improved microtensile bond strength and reduced nanoleakage compared to resveratrol alone.
  • Encapsulation eliminated cytotoxicity associated with high-concentration free resveratrol.
  • Enhanced remineralization was observed in both recombinant type I collagen and demineralized dentin samples.
  • MMP-9 activity was more strongly inhibited by Res@Q[n] than by free resveratrol at equivalent doses.

Methodology

This was an in vitro laboratory study using analytical chemistry, quantum chemical modeling, cell cytotoxicity assays, collagen and dentin mineralization models, microtensile bond strength testing, nanoleakage evaluation, and MMP colorimetric and zymography assays. Complexes were synthesized and characterized structurally before functional testing. No animal or human subjects were involved.

Study Limitations

The study is entirely in vitro, limiting direct extrapolation to clinical dental procedures in living patients. Long-term biocompatibility and stability of Res@Q[n] complexes in the oral environment were not evaluated. The study does not address manufacturing scalability or integration into existing commercial dental adhesive systems.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: